Confidential · TTC × SCC / TLI

The Longevity Institute

Technology & Integration Plan · prepared for Michael London & Dr. Chad Denman

If you need a code, contact ernie@tacotruckcreative.com

Confidential

Breathe better.
Sleep healthier.
Live longer.

The technology and integration architecture behind Sleep Cycle Center, The Longevity Institute, and a national network of sleep-apnea-led longevity practices.

Prepared by Taco Truck Creative · For FORBventures & Sleep Cycle Center · May 11, 2026
30+
Diseases linked to untreated sleep apnea
~1B
People worldwide undiagnosed
300
Trained dentists in Chad's network
3× / 10×
Top-line / bottom-line target, Austin '26
01 · Vision Alignment
01

What you've described is not a clinic chain. It's a longevity platform with sleep apnea as the front door.

Your View from 30,000 Feet document defines four key pieces of the puzzle: sleep apnea treatments, wearable devices, AI, and a referral plus treatment ecosystem. The first is yours. The next three are where every competitor will get stuck. That's where this document begins.

A
Austin SCC as the prototype

3× top, 10× bottom in 2026. Operationalized, documented, instrumented, so it can be cloned.

B
Wearable plus AI changes care

Continuous monitoring, contextual interpretation, daily action. Not a wellness gimmick. A reimbursable clinical signal stream.

C
TLI is the value driver

MSO above the network. Owns brand, technology, data, and patient relationships. Investor-grade structure from day one.

02 · The Stack
02

A bespoke six-layer architecture, built for this. Not adapted from someone else's MSO.

Every existing sleep-medicine SaaS treats the patient as a row in a database. Ours treats the patient as a longitudinal physiological signal, and the franchisee as the operator of a high-yield clinical product, not the manager of an EMR.

TLI Platform Architecture
Layered, regulated, replaceable at every interface
L6
Patient experience
iOS, Android, web
Morning AI report
Trends & baselines
Compliance coach
GP auto-summary
L5
Franchisee operating system
Web, multi-role
Patient pipeline
Insurance & RCM
Marketing autopilot
Training LMS
L4
MSO operations cloud
TTC build
Multi-loc rollups
Cohort analytics
Compliance audit
Investor reporting
L3
AI & clinical reasoning
LLMs plus custom models
Context engine (RAG)
Anomaly & trend detection
Inform-not-diagnose guardrail
Drug + comorbidity check
L2
Data platform
FHIR-aligned, HIPAA
Patient longitudinal store
Telemetry ingest
Consent & access ledger
De-identified research vault
L1
Signal acquisition
Hardware, wearables, HSAT
Home sleep test (HSAT)
Watch / ring / band
In-ear biosensing
CPAP / oral / CGM / BP
Built once

Multi-tenant from day one. New franchisee equals new tenant ID. Branding, pricing, payor mix, comms templates configurable per location.

Compliant by design

HIPAA, SOC 2 path, FDA 21 CFR 820 awareness for any SaMD claim. Data segregation per state for CPOM and anti-kickback boundaries.

Replaceable interfaces

Every external dependency, payor, device, model, EMR, sits behind a TTC interface so vendor lock-in stays under our control, not theirs.

Clinical claim discipline

What the platform does, and what it does not.

  • The platform does not diagnose sleep apnea from wearable data.
  • Wearables support patient engagement, trend monitoring, adherence coaching, and clinician review.
  • Diagnostic claims remain tied to approved testing pathways, clinician interpretation, and applicable regulatory standards.
  • AI outputs are decision-support and patient-education tools unless and until separately validated and cleared.
03 · Integrations
03

Eight integration plays most sleep-medicine platforms are not built to operationalize.

Sleep-medicine software today connects to one CPAP cloud and one billing clearinghouse. We're going to connect to the entire physiological surface of the patient, then translate that into the kind of clinical signal that justifies the longevity-platform thesis you're raising on.

★ Signature integration

Apple AirPods as the
next clinical signal layer.

Apple is steadily turning AirPods into a health interface. AirPods Pro 2 already support regulated hearing-health features, including Apple's FDA-authorized OTC Hearing Aid Feature, Hearing Test, Hearing Protection, and Live Listen. AirPods Pro 3 extends the platform further with in-ear heart-rate sensing for workouts. Together, these moves point to a clear direction: ear-worn devices are becoming a mainstream channel for health data.

Apple's public patent filings go further. The company has filed applications describing earbud-based biosignal sensing using in-ear and around-ear electrodes, including EEG-style neural signal measurement. These filings do not mean Apple has shipped EEG AirPods, and they do not guarantee Apple will expose neural data to developers. But they strongly support the strategic thesis that the ear is becoming a high-value sensing location for hearing, cardiac, motion, and potentially neural signals.

TLI's opportunity is to build the sleep-medicine interpretation layer ahead of the hardware curve. We can begin today with public Apple frameworks: HealthKit, audiogram data, heart-rate data where available, motion data, and audio / hearing-health workflows. As Apple and other ear-worn platforms expose richer biosignals, TLI is positioned to become the clinical destination for interpreting that data in the context of sleep health.

This is not a bet that AirPods are a clinical EEG device today. It is a bet that the world's most widely adopted ear-worn platform is moving toward clinical-grade sensing, and that sleep medicine needs a trusted interpretation layer when those signals become available.

Patent landscape · public filings
USPTO
US20230225659A1
Biosignal Sensing Device Using Dynamic Selection of Electrodes. Earbud-based biosignal sensing using electrodes positioned in or around the ear, including EEG measurement and electrode configurations for biological signal capture.
US20170078780A1
Earbuds with Biometric Sensing. Earbuds configured with biometric sensors, including sensors positioned against the tragus for biometric measurements. Supports Apple's longer-term interest in ear-based biometric sensing.
AppleHealth
HealthKit already exposes heart-rate samples and audiogram samples. AirPods Pro 2 and Pro 3 support Hearing Test and Hearing Aid functionality, with audiogram data stored in the Health app.
Roadmap
In-ear EEG and related ear-based biosignals are an emerging research and patent direction, not a commercial Apple capability today. The strategic opportunity is to architect TLI so it can absorb these signal classes if and when they become available through approved consumer or clinical pathways.
We do not need a private Apple partnership to begin building the integration strategy. We can start with public Apple frameworks today. If Apple exposes EEG-class or related biosignal data through HealthKit, ResearchKit, or another approved developer pathway, TLI's platform should be ready to integrate it quickly because the clinical workflow, consent model, and interpretation layer will already be in place.
02
Wearable

Oura Ring · Whoop · Garmin

HRV, recovery, body temperature, sleep architecture cross-validation. Three rings is better than one. Agreement-vs-disagreement signals improve confidence intervals on AHI estimation.

03
Continuous metabolic

Dexcom G7 · Libre 3 · Levels

CGM as a sleep-quality biomarker. Apnea events drive overnight glucose excursions. Correlating the two is a powerful patient-education moment and a publishable signal.

04
Cardiovascular

Withings ScanWatch · Omron · KardiaMobile

Continuous BP and ECG. Untreated apnea drives nocturnal hypertension. Objective BP normalization post-treatment is the clinical proof point that justifies premium pricing.

05
Environmental

Eight Sleep Pod 4

Bed-level temperature, HRV, sleep-stage data. The only ecosystem that can act on a recommendation overnight by adjusting bed temperature in response to apnea-related arousal.

06
CPAP cloud

ResMed AirView · Philips Care Orchestrator · React Health

Compliance and AHI streaming directly into the franchisee dashboard. 90-day adherence drives reimbursement. Auto-flagged non-compliant patients get a coach call within 24h.

07
Insurance / RCM

Availity · Change Healthcare · Eligible

Real-time benefits verification, prior auth tracking, claims posting. The "we'll handle insurance" promise to dentist franchisees becomes a real, measurable workflow. Not a sales-deck line.

08
Clinical research network
Warm intro available

The Marwan Sabbagh / Alzheimer's correlation lane

Dr. Marwan Sabbagh is one of the most cited Alzheimer's researchers in the world, the national voice on the topic, and a personal childhood friend of Ernie's. He is reachable.

Sleep apnea is now established in the literature as a major contributor to amyloid clearance dysfunction and Alzheimer's progression. A formal advisory relationship with Sabbagh, appointed to the TLI Scientific Advisory Board, gives the platform a clinical research narrative no competitor can match: "the sleep-medicine network that publishes Alzheimer's-prevention data."

Ernie will not initiate outreach until you green-light.

Other introducible advisory roles
› Mayo Clinic Sleep Center referral pathway
› Portland-based heart team you've referenced
› Stanford Sleep Medicine alumni network (TTC has agency-side relationships)
› AASM (Am. Academy of Sleep Medicine) accreditation lane for franchisees
Each advisor relationship turns into a clinical content stream. Patient education, franchisee CME, investor narrative, PR.
07 · Franchise Operations
07

The franchise architecture isn't theoretical. We've already built one.

Franchise systems are not built in strategy documents. They are built in the tension between brand standards, local operator reality, unit economics, training, compliance, and cash flow. TTC brings the rare combination of brand-building, software-building, and real franchise operating experience.

Operator-side, 30+ years
Master franchisee, country scale

Ernest Koury · selected operator track

Little Caesars · West Texas plus Southern New Mexico

Largest franchisee in the territory. Multi-unit P&L. Hiring, training, vendor management, real estate, marketing. Operated as principal for years.

Little Caesars · Australia (sole continental franchisee)

2013 to 2019. Built a country's franchise system from zero. 16 stores in Sydney. Site selection, build-out, training systems, supply chain, multi-state regulatory navigation, multi-currency, expat ops.

Sign manufacturing · 30,000 sq ft facility

Largest sign manufacturer in the Southwest US. Vertical integration into the brand-standardization layer that every franchise system relies on.

Taco Truck Creative (2013) · agency-side

Operated in parallel with the franchise stores. TTC turned Callaway from #4 to #1 in two years and held it for 13. Currently servicing the LPGA Tour, Mark Wahlberg's Municipal, and Lab Golf.

Smeltzer's Phase II proposes to write the operational standards, financial architecture, franchise flexibility framework, and growth roadmap. Ernie has lived all four. At country scale. With his own capital at risk. In the world's most regulated franchise category. This phase is not consulting work to outsource. It is operator work, and it should be led by someone who's been the operator.
Site selection

Population density, payor mix per ZIP, dentist-density saturation, drive-time isochrones, competitor mapping.

Franchisee economics

Unit-economics worksheet, $20K/mo bottom-line target reverse-engineered to patient throughput, payor mix, treatment plan.

Standards & flexibility

Brand non-negotiables vs. operational latitude. The line that separates franchise integrity from franchisee revolt. We've drawn it before.

08 · Smeltzer Inc.
08

Smeltzer fits, narrowed.

Per your instruction, we've assumed Smeltzer's team is every bit as accomplished as the proposal conveys. The question then becomes one of fit, not capability. Here is the lane where Smeltzer is genuinely best, and the reason the rest belongs with TTC.

Keep
Phase III audit

Boots-on-ground shadow-patient walkthrough at both Austin clinics. Anonymous, embedded, reported. This is genuinely the most effective way to find the gaps no internal staff sees anymore. Smeltzer is local-Austin in a way TTC isn't. Treat as a fixed-fee discrete deliverable. Two to three days of fieldwork, roughly a 30-page gap report.

Keep · conditional
Phase V investor introduction

If Smeltzer's "active investor relationship in position toward $100M" is real and named, it is his single most valuable contribution. Hold him on retainer for the introduction plus ongoing investor-relations advisory. Validate the relationship privately before relying on it.

Reassign
Phases I, II, IV
  • Phase I (Brand) › TTC. Travis Graham plus Dave Huerta brought TaylorMade and Callaway to #1. Smeltzer's case studies are inventory and fragrance.
  • Phase II (Business plan, franchise framework, growth roadmap) › Ernie plus TTC. Operator track at country-master-franchisee scale. Smeltzer has no franchise case studies on record.
  • Phase IV (Training, sales scripts, pricing, marketing) › TTC plus Ernie. Marketing and comms is TTC core competency. Training systems built for an entire continent of Little Caesars stores.
A clean division of labor

The cleanest structure is not either / or. Smeltzer is best used as a focused Austin-based audit and investor-access resource. TTC should lead the brand, platform, franchise operating system, and commercialization architecture. That gives each party a defined lane, avoids duplicated fees, and keeps the engagement tied to measurable outcomes.

09 · Deal mechanics
09

Anchor partner. Equity-led. Sharp pencil pre-Series-A.

Per your structure on the call: zero up front, options at signing, deferred fees through Series A, current basis post-close, options ladder tied to delivery. We're aligned. Below is how the work maps to that structure.

Phase 0 · Now to NDA signed
  • NDA executed (Taco Truck Creative, LLC)
  • Term sheet finalized via Hal
  • This deck presented Mon May 11
Phase 1 · Q2 ($1 to $2M raise)
  • Brand identity (SCC plus TLI plus dentist sub-brand)
  • Austin SCC marketing engine live (3× / 10× plan)
  • Patient app v1 plus AI report (HSAT-only signal)
  • Franchisee dashboard alpha
Phase 2 · Q3
  • Wearable telemetry ingest (Watch + Oura + Whoop + CGM)
  • Insurance / RCM integration
  • Franchisee recruitment platform live
  • First 5 dentist franchisees onboarded as pilots
Phase 3 · Q4 to Series A
  • MSO command center plus investor reporting
  • Series A deck production (TTC) plus warm investor activation (Smeltzer)
  • Apple AirPods biosensor SDK integration scaffold
  • National launch readiness · Q1 2027

Compensation structure (per call)

At signing
Equity options grant. Tax-favored treatment. Defined deliverable list day-one.
Pre-Series A window
Sharp-pencil fee schedule. Portion of fees deferred against the Series A close.
Post-Series A
Current-basis fees. Additional options tied to delivery milestones. Material upside.

Terms to be documented

Each bucket below carries a number or formula in the term sheet. No bucket stays vague.

01
Option grant at signing
Strike, vesting schedule, accelerator triggers
02
Deferred fee amount or formula
Total cap, conversion at Series A close
03
Cash fee schedule, pre-Series A
Monthly retainer, milestone payments, cap on burn
04
Cash fee schedule, post-Series A
Current-basis market rate, true-up of deferred
05
Milestone-triggered option ladder
Specific delivery gates, additional grants per gate
06
IP ownership and licensing
Platform IP, brand IP, work-for-hire scope, license-back rights
07
Exclusivity / category restriction
Sleep-apnea / longevity-MSO category lock, geographic scope
08
Termination rights
For-cause, for-convenience, vested-options treatment, IP at term
09
What happens if Series A never closes
Deferred-fee conversion path, IP ownership at wind-down, options treatment, runway-extension scenarios
10 · Decisions required this week
10

Four decisions. None take long.

So that we can move from this conversation into shipped work, the items below need a yes / no / hold from you and Chad before the end of the week. Every later step depends on these.

01
Confirm TTC as lead platform, brand, and commercialization partner.
Anchor partner role, equity-led, scope per §07 and §09 of this deck.
02
Approve prototype expansion into Phase 1 scope.
Move the patient, franchisee, and MSO surfaces from prototype into production build against the Q2 milestone list.
03
Confirm Smeltzer scope is limited to Austin audit and investor-intro validation.
Phase III shadow-patient audit at the two Austin clinics. Phase V conditional on validated warm-investor relationship. Phases I, II, IV reassigned to TTC.
04
Green-light or hold on Sabbagh outreach.
If green-lit, Ernie initiates a warm conversation with Dr. Marwan Sabbagh about a TLI Scientific Advisory Board appointment. No outreach happens otherwise.
One short follow-up call after these four lands turns this from a strategy meeting into a signed engagement.